Electronic cigarettes (e-cigarettes) are novel battery powered nicotine delivery devices. Although the prevalence of e-cigarette use is increasing, there remains a lack of research regarding their safety and addiction potential. A growing body of research suggests that like tobacco cigarettes, e-cigarettes also share a high rate of co-use with alcohol. Previous research has found that smoking tobacco cigarettes while drinking alcohol may produce greater rewarding effects. However, there are over 5,000 different compounds found in tobacco smoke in addition to nicotine, some of which are also psychoactive. A challenge to dissociating the effects of nicotine from tobacco has been administering nicotine in a way that is comparable to smoking a cigarette, since the route of administration influences the subjective effects of nicotine. E-cigarettes can deliver amounts of nicotine similar to tobacco cigarettes and allow for a matched placebo control (same flavor, device, and sensory experience) between the nicotine and the nicotine-free e-cigarette condition. The proposed research will take advantage of this novel route of administration to examine the hypothesis that alcohol and nicotine delivered through an e-cigarette have combined pharmacological effects that could support their co- use. This hypothesis will be addressed with the following two Specific Aims: (1) To determine if nicotine e- cigarettes have greater subjective rewarding effects when used in combination with alcohol, and (2) To determine if ad libitum nicotine e-cigarette use increases after drinking alcohol. The proposed research will use a three-day within-subject human laboratory study. On each test day participants will drink an alcohol or placebo-alcohol beverage. Participants will then use their own e-cigarette (with or without nicotine) in a standardized e-cigarette puffing protocol, followed by a 2-hour ad libitum e-cigarette use session. Each participant will complete three experimental conditions on three separate days: (1) nicotine e-cigarette + alcohol, (2) nicotine e-cigarette + placebo alcohol, and (3) nicotine-free e-cigarette + alcohol. Data from the standardized e-cigarette session will be used to assess the subjective and cardiovascular effects of e- cigarettes when used alone or in combination with alcohol. The ad libitum session will provide information on the use behavior and plasma nicotine levels reached when e-cigarettes are used alone versus after drinking alcohol. This work will provide important training in human pharmacology research as I transition from work in mice to humans. This research and training will create a solid foundation for me to become an independent investigator. Knowledge produced by the proposed study will have important implications for informing future regulatory actions regarding e-cigarettes and other alternative nicotine delivery devices and improve our understanding of the role of nicotine in the co-morbid use of alcohol and tobacco.

Public Health Relevance

Electronic cigarettes (e-cigarettes) are novel nicotine delivery devices that are rapidly growing in popularity. Nicotine products and alcohol share a high rate of co-use making it important to determine if nicotine delivered through an e-cigarette and consumption of alcohol have combined pharmacological effects that could lead to greater risk for continued use and dependence. Knowledge produced by the proposed study will have important implications for informing future regulatory actions regarding e-cigarettes and other alternative nicotine delivery devices and improve our understanding of the role of nicotine in the co-morbid use of alcohol and tobacco.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32DA042554-02
Application #
9392857
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Kautz, Mary A
Project Start
2016-12-01
Project End
2018-11-30
Budget Start
2017-12-01
Budget End
2018-11-30
Support Year
2
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94118
Gubner, Noah R; Williams, Denise D; Pagano, Anna et al. (2018) Menthol cigarette smoking among individuals in treatment for substance use disorders. Addict Behav 80:135-141
Gubner, Noah R; Thrul, Johannes; Kelly, Oona A et al. (2018) Young adults report increased pleasure from smoking cigarettes when drinking alcohol but not when using marijuana. Addict Res Theory 26:71-76
Gubner, Noah R; Pagano, Anna; Tajima, Barbara et al. (2018) A Comparison of Daily Versus Weekly Electronic Cigarette Users in Treatment for Substance Abuse. Nicotine Tob Res 20:636-642
Gubner, Noah R; Guydish, Joseph; Humfleet, Gary L et al. (2017) Nicotine biomarkers and rate of nicotine metabolism among cigarette smokers taking buprenorphine for opioid dependency. Drug Alcohol Depend 178:267-270